gi
Gilead Sciences
GILD
NASDAQ $139.71
How effective is Gilead Sciences's capital allocation strategy?
Gilead Sciences shows solid capital allocation. Returns on capital exceed the cost of capital, and management balances reinvestment with shareholder returns reasonably well. There is room for improvement, but overall capital deployment creates value.
Read the full report on Gilead Sciences and explore the other sections
Overview of Gilead Sciences
Does Gilead Sciences have a strong competitive moat?
Does Gilead Sciences have pricing power in its industry?
How predictable is Gilead Sciences's business?
Is Gilead Sciences financially strong?
How effective is Gilead Sciences's capital allocation strategy?
Does Gilead Sciences have high-quality management?
What is the fair value of Gilead Sciences stock?